Publications by authors named "Yuta Horie"

Article Synopsis
  • Oryzamutaic acids, which come from a rice mutant and have a unique nitrogen-containing structure, are believed to have beneficial properties but are hard to study due to their variety and low concentrations.
  • The study developed an easy lab method to produce these acids using an enzyme called L-lysine ε-dehydrogenase (LysDH) from Agrobacterium tumefaciens, which was first cloned and expressed in E. coli.
  • The researchers successfully created 1.6 mg of oryzamutaic acid H from 100 mg of L-lysine, discovering that it has UVA absorption and remains stable across different temperatures and pH levels, making it the first report of its enzymatic synthesis
View Article and Find Full Text PDF
Article Synopsis
  • Definitive chemoradiotherapy (dCRT) with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) is a promising first-line treatment for advanced cervical esophageal squamous cell carcinoma (ESCC), aimed at preserving the larynx.
  • In a study of 18 patients, the treatment achieved a complete response (CR) in 15 individuals, but 7 of those experienced recurrence, while 2 had stable disease and 1 progressive disease.
  • The 3-year survival rates were reported as 44.2% overall, with 47.7% disease-free and 48.6% disease-specific, suggesting that while the treatment shows potential,
View Article and Find Full Text PDF

The Keap1-Nrf2 system is central for mammalian cytoprotection against various stresses and a drug target for disease prevention and treatment. One model for the molecular mechanisms leading to Nrf2 activation is the Hinge-Latch model, where the DLGex-binding motif of Nrf2 dissociates from Keap1 as a latch, while the ETGE motif remains attached to Keap1 as a hinge. To overcome the technical difficulties in examining the binding status of the two motifs during protein-protein interaction (PPI) simultaneously, we utilized NMR spectroscopy titration experiments.

View Article and Find Full Text PDF